Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First gene gun clinical trial announced by Auragen

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996

Antitumor antibody for medulloblastoma Rx claimed by Chugai

Nov. 1, 1996

Taxotere now approved in 35 countries

Nov. 1, 1996

Polyamine antimetabolites claimed by Ciba-Geigy

Nov. 1, 1996

IND for GL-331 approved in Taiwan

Oct. 25, 1996

Therapeutic polyamine compounds available from NIH

Oct. 25, 1996

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

NCI to codevelop MGI anticancer drug

Oct. 25, 1996

Polypeptide product of DRA gene as potential therapy in colorectal carcinoma available for licensing

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...